1 Introduction 9
1.1 Industry Definition and Research Scope 9
1.1.1 Industry Definition 9
1.1.2 Research Scope 10
1.2 Research Methodology 13
1.2.1 Overview of Market Research Methodology 13
1.2.2 Market Assumption 14
1.2.3 Secondary Data 14
1.2.4 Primary Data 14
1.2.5 Data Filtration and Model Design 15
1.2.6 Market Size/Share Estimation 16
1.2.7 Research Limitations 17
1.3 Executive Summary 18
2 Market Overview and Dynamics 21
2.1 Market Size and Forecast 21
2.1.1 Impact of COVID-19 on World Economy 22
2.1.2 Impact of COVID-19 on the Market 24
2.2 Major Growth Drivers 31
2.3 Market Restraints and Challenges 39
2.4 Emerging Opportunities and Market Trends 42
2.5 Porters Fiver Forces Analysis 46
3 Segmentation of Europe Market by Synthesis 50
3.1 Market Overview by Synthesis 50
3.2 Synthetic API 52
3.2.1 Branded Synthetic API 53
3.2.2 Generic Synthetic API 54
3.3 Biotech API 55
3.3.1 Biotech API by Drug Type 56
3.3.1.1 Monoclonal Antibodies 57
3.3.1.2 Recombinant Proteins 58
3.3.1.3 Vaccines 59
3.3.1.4 Other Biotech APIs 60
3.3.2 Biotech API by Category 61
3.3.2.1 Innovative Biologic API 62
3.3.2.2 Generic Biosimilar API 63
3.3.3 Biotech API by Expression Technology 64
3.3.3.1 Mammalian Expression 65
3.3.3.2 Microbial Expression 66
3.3.3.3 Yeast Expression 67
3.3.3.4 Insect Expression 68
3.3.3.5 Other Expression Technologies 69
3.4 HPAPI 70
3.4.1 Branded HPAPI 71
3.4.2 Generic HPAPI 72
4 Segmentation of Europe Market by Manufacturing Process 73
4.1 Market Overview by Manufacturing Process 73
4.2 Captive Manufacturing 75
4.2.1 Branded Captive API 76
4.2.2 Generic Captive API 77
4.3 Merchant Manufacturing 78
4.3.1 Merchant Manufacturing by Drug Type 79
4.3.1.1 Branded Merchant API 80
4.3.1.2 Generic Merchant API 81
4.3.2 Merchant Manufacturing by Drug Synthesis 82
4.3.2.1 Merchant Synthetic API 83
4.3.2.2 Merchant Biotech API 84
5 Segmentation of Europe Market by Therapeutic Application 85
5.1 Market Overview by Therapeutic Application 85
5.2 Infectious Diseases 87
5.3 Oncology 88
5.4 Ophthalmology 89
5.5 Cardiovascular Disorders 90
5.6 Central Nervous System 91
5.7 Pulmonary Disorders 92
5.8 Orthopedics 93
5.9 Other Applications 94
6 Segmentation of Europe Market by Drug Type 95
6.1 Market Overview by Drug Type 95
6.2 Branded Prescription Drugs 97
6.3 Generic Prescription Drugs 98
6.4 OTC Drugs 99
7 European Market 2021-2028 by Country 100
7.1 Overview of European Market 100
7.2 UK 103
7.3 France 105
7.4 Germany 107
7.5 Spain 109
7.6 Italy 111
7.7 Russia 113
7.8 Rest of European Market 115
8 Competitive Landscape 117
8.1 Overview of Key Vendors 117
8.2 New Product Launch, Partnership, Investment, and M&A 120
8.3 Company Profiles 121
AbbVie Inc. 121
Astrazeneca 123
Aurobindo Pharma Ltd. 128
BASF 131
Bayer AG 134
Boehringer Ingelheim 138
Catalent Inc. 143
Dr. Reddy's Laboratories 146
F. Hoffmann-La Roche 148
GlaxoSmithKline plc 150
Lonza Group 155
Lupin Limited 160
Merck & Co., Inc. 163
Mylan NV 166
Novartis International AG 169
Pfizer Inc. 172
Sanofi 177
Sun Pharmaceutical Industries Ltd. 180
Teva Pharmaceutical Industries Ltd. 183
Thermo Fisher Scientific 185
9 Investing in Europe Market: Risk Assessment and Management 187
9.1 Risk Evaluation of Europe Market 187
9.2 Critical Success Factors (CSFs) 190
Related Reports and Products 193